tirzepatide injection or pill vs. Semaglutide for Weight Loss Race to launch weight-loss pills

It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

The only problem I seem to be having is reaching the company to get information from them

Sublingual placement ensures 7080% bioavailability, whereas swallowing reduces it to approximately 510%

In a head-to-head trial, tirzepatide users lost about 20% of body weight versus roughly 15% with semaglutide over 72 weeks

This leads to greater feelings of fullness, lower blood sugar, and, with a healthy diet and regular exercise, significant weight loss